A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease

BACKGROUND: In preclinical models, antagonism of metabotropic glutamate receptor 5 (mGluR5) reduces transient lower oesophageal sphincter relaxations (TLOSRs) and increases LOS pressure. This study evaluated the effect of ADX10059, a potent, selective, negative allosteric modulator of mGluR5, on oes...

Descripción completa

Detalles Bibliográficos
Autores principales: Keywood, C, Wakefield, M, Tack, J
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2009
Materias:
Oesophagus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719084/
https://www.ncbi.nlm.nih.gov/pubmed/19460767
http://dx.doi.org/10.1136/gut.2008.162040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719084/
https://www.ncbi.nlm.nih.gov/pubmed/19460767
http://dx.doi.org/10.1136/gut.2008.162040

Ejemplares similares